Viramune, Retardtabletten

7680620770014 CH-62077 J05AG01 08.03.0.

Active substances:

Viramune, Retardtabletten
Viramune, Retardtabletten
1 / 2
Fiches Amavita / Sun Store / Coop Vitality

Details

Product number
6207701
CPT
-
Packaging group
30
Unit
Tablette(n)
Composition
nevirapinum 400 mg, lactosum monohydricum 400 mg, hypromellosum, magnesii stearas, E 172 (flavum) pro compresso.

Articles (1)

Viramune, Retardtabletten
Tabletten
30
View

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
nevirapinum
400.0 MG Substance Wirkstoff (Principe actif)
lactosum monohydricum
400.0 MG Substance HBESI
hypromellosum
- Substance HNIDK
magnesii stearas
- Substance HNIDK
E 172 (flavum)
- Substance FTODK

Authorization holder

Boehringer Ingelheim (Schweiz) GmbH

4057 Basel

Authorization information

Swissmedic authorization number
62077
Drug name
Viramune, Retardtabletten
Galenic form
RETT
ATC Code
J05AG01
Authorization status
Z
Dispensation category
A
First authorization
10/01/2012
Authorization expiration date
31/08/2026
IT number
08.03.0.
Domain
Human medicine
Field of application
HIV-Infektionen

Packaging details

Description (FR)
VIRAMUNE cpr ret 400 mg 30 pce
Description (DE)
VIRAMUNE Ret Tabl 400 mg 30 Stk
Market launch
10/01/2012
Market withdrawal
31/08/2026
Narcotic (BTM)
No

Available generics

Nevirapin Sandoz Retard, Retardtabletten
CHF 193.35
View
Nevirapin Viatris, Retardtabletten
CHF 193.35
View
Buy us a coffee Explore the data